LONDON, July 13, 2017 /PRNewswire/ -- Highlights
KEY FINDINGSThe Europe weight loss and weight management diet market is estimated to grow at a CAGR of 2.33%. The revenue generated for this market is expected to increase from $2534 million in 2016 to $3120 million by 2025. The growing pace of obesity and chronic diseases combined with the rising geriatric population in Europe are generating a demand for the weight management products.MARKET INSIGHTSThe market is divided on the basis of the type of weight management products and the distribution channels. By type, the market is further segmented as slimming teas, OTC obesity, supplement nutrition drinks, weight loss supplements and meal replacement products. The Meal replacements are intended for the purpose of weight loss or weight gain, wound recovery and physical fitness and is currently leading the market by type. On the basis of the distribution channel, the market is further segmented into retail stores and online retailing. The retail stores account for the largest share of the market due to a wide range of branded products that they have to offer to the consumers. However, online shopping is fast becoming a trend in this region and is expected to show the highest growth in CAGR during the forecasted years.COMPETITIVE INSIGHTS The top players in the market are Kellogg Company, Nestlé, Nutrisystem Inc, Abbott Nutrition, Iovate Health Sciences, Creative Bioscience, Weight Watchers, Amway, Glanbia, Danone, Herbalife, Atkins Nutritionals Inc, Gsk, and Jenny Craig Inc.
Download the full report: https://www.reportbuyer.com/product/4976563/About ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishershttp://www.reportbuyer.com For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: email@example.com Tel: +44 208 816 85 48 Website: www.reportbuyer.com
View original content:http://www.prnewswire.com/news-releases/europe-weight-loss-and-weight-management-diet-market-expected-to-grow-to-3120-million-by-2025-300488234.html
Subscribe to our Free Newsletters!
Lazy eye or amblyopia occurs when sight in one eye is less than the other in early childhood due to ...
Tracheal or windpipe cancer is a rare cancer and its cause is unclear. The most common squamous ...
Tecovirimat can be used to treat smallpox disease in adult and pediatric patients who weigh at ...View All